Clinical Trial Update: Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Cancer

View source ↗

Summary

A clinical trial update evaluating how gemcitabine treatment influences immunological and serological profiles in patients with pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Blood Transfusion Centre of Slovenia | Conditions: Pancreatic Tubular Adenocarcinoma | Status: UNKNOWN